India cord stem cell banking market is expected to grow with a healthy CAGR of 12.6% in the forecast period of 2019 to 2026. The market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation
By Source (Umbilical Cord, Placenta, Amniotic Sac, Amniotic Fluid), Application (Blood Disorders/Bone Marrow Failure, Cancers, Neurologic Disorders, Genetic Disorder, Metabolic Disorders, Immune Disorders, Others), Mode of Treatment (Autologous, Allogeneic), Service Type (Sample Preservation and Storage, Sample Processing, Sample Analysis, Sample Collection and Transportation), Cord Blood Banking (Private Cord Blood Banks, Public Cord Blood Banks)

Some of the major factors contributing to the growth of the India cord stem cell banking market are:

> Increasing birth rate

> Increasing presence of beta-thalassemia and others blood disorders

Key Market Players

The key market players for India cord stem cell banking market are listed below:

> Cordlife Group Limited
> LifeCell
> Mycord (CelluGen Biotech Pvt. Ltd.)
> Reliance Life Sciences
> Cryoviva India
> Global Cord Blood Corporation
> Cryo-Cell International, Inc.
> REGROW BIOSCIENCES PVT LTD
> ReeLabs Pvt. Ltd.
> Others